COMPARE CPM-RMI Trial: Intramyocardial Transplantation of Autologous Bone Marrow-Derived CD133+ Cells and MNCs during CABG in Patients with Recent MI: A Phase II/III, Multicenter, Placebo-Controlled, Randomized, Double-Blind Clinical Trial

Cell J. 2018 Oct;20(3):449. doi: 10.22074/cellj.2018.6018. Epub 2018 May 28.

Abstract

This article published in Cell J (Yakhteh), Vol 20, No 2, Jul-Sep 2018, on pages 267-277, four affiliations (1, 4, 5, and 10) were changed based on authors request.

Keywords: Attitudes; Regenerative Medicine; Stem Cell; Treatment.

Publication types

  • Published Erratum